Prosecution Insights
Last updated: October 04, 2026

Adama Agan Ltd.

Technology area: Biotechnology & Pharmaceuticals

7 pending office actions • 4 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Adama Agan Ltd. has 8 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 5 distinct art units, reflecting biological or pharmaceutical subject matter. The prosecution involves 7 distinct examiners, indicating that most of the 8 pending actions are being handled by different individuals.

The busiest examiner, PAK, JOHN D, is currently managing 2 busiest_examiner_pending office actions. This represents a portion of the 8 total pending office actions. The remaining actions are handled by the rest of the 7 distinct examiners, requiring the company to manage multiple perspectives across the 5 distinct art units involved.

The presence of 8 pending office actions in 5 distinct art units suggests that the company's applications cover several specialized areas within Biotechnology & Pharmaceuticals. With 7 distinct examiners involved, the company must ensure its prosecution strategy is consistent across these individuals. The 2 actions assigned to PAK, JOHN D, are the only instance of examiner overlap in the current 8 pending actions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

7
Total Pending OAs
3
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (43%)
4
Medium (57%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (14%)
§103 only4 (57%)
Multi-statute (no §101)2 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAK, JOHN D 2 52.4% +37.7%
WAX, ROBERT A 1 25.0% +3.9%
ZHANG SPIERING, DONGXIU 1 45.2% +70.9%
WORSHAM, JESSICA N 1 56.3% +56.3%
JOHNSON, DANIELLE D 1 45.0% +12.9%
HIRT, ERIN E 1 40.3% +23.0%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18877889 METHOD OF APPLICATION OF HERBICIDAL ACTIVE INGREDIENTS IN DIFFERENT STAGES WAX, ROBERT A —
18719973 STABLE SUSPOEMULSIONS PAK, JOHN D —
18547527 HERBICIDAL COMPOSITIONS COMPRISING IMIDAZOLINONE-BASED ACETOLACTATE SYNTHASE INHIBITORS AND USES THEREOF PAK, JOHN D —
18012409 THE USE OF SAFENERS TO IMPROVE TOLERANCE OF ACCASE TOLERANT SORGHUM CROP TO HERBICIDES JOHNSON, DANIELLE D —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18560244 STABLE AGROCHEMICAL SUSPENSION CONCENTRATE COMPOSITIONS ZHANG SPIERING, DONGXIU 73d overdue
18719973 STABLE SUSPOEMULSIONS PAK, JOHN D —
18280120 SOLID FORMS OF SAFLUFENACIL-SODIUM AND SAFLUFENACIL-POTASSIUM, PROCESS OF PREPARATION AND USE THEREOF WORSHAM, JESSICA N —
18547527 HERBICIDAL COMPOSITIONS COMPRISING IMIDAZOLINONE-BASED ACETOLACTATE SYNTHASE INHIBITORS AND USES THEREOF PAK, JOHN D —
18012409 THE USE OF SAFENERS TO IMPROVE TOLERANCE OF ACCASE TOLERANT SORGHUM CROP TO HERBICIDES JOHNSON, DANIELLE D —
17792306 Solid State Form of Pyroxasulfone HIRT, ERIN E —

Top Art Units

Art UnitApps
1699 2
1616 2
1615 1
1614 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18877889 METHOD OF APPLICATION OF HERBICIDAL ACTIVE INGREDIENTS IN DIFFERENT STAGES WAX, ROBERT A — §103 Non-Final OA — Pending Dec 20, 2024
18719973 STABLE SUSPOEMULSIONS PAK, JOHN D 1699 §101§103§112DP Non-Final OA — Pending Jun 14, 2024
18560244 STABLE AGROCHEMICAL SUSPENSION CONCENTRATE COMPOSITIONS ZHANG SPIERING, DONGXIU 1616 §103 Final Rejection 73d overdue Pending Nov 10, 2023
18280120 SOLID FORMS OF SAFLUFENACIL-SODIUM AND SAFLUFENACIL-POTASSIUM, PROCESS OF PREPARATION AND USE THEREOF WORSHAM, JESSICA N 1615 §103 Final Rejection — Pending Sep 01, 2023
18547527 HERBICIDAL COMPOSITIONS COMPRISING IMIDAZOLINONE-BASED ACETOLACTATE SYNTHASE INHIBITORS AND USES THEREOF PAK, JOHN D 1699 §102§103 Final Rejection — Pending Aug 23, 2023
18012409 THE USE OF SAFENERS TO IMPROVE TOLERANCE OF ACCASE TOLERANT SORGHUM CROP TO HERBICIDES JOHNSON, DANIELLE D 1614 §102§103§112Other Non-Final OA — Pending Dec 22, 2022
17792306 Solid State Form of Pyroxasulfone HIRT, ERIN E 1616 §103 Final Rejection — Pending Jul 12, 2022

Managing Adama Agan Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month